Pfizer’s updated COVID-19 booster expected Sept. 1

Published August 27, 2022 4:07 PM

(CNN) - The Food and Drug Administration (FDA) is expected to approve Pfizer's updated booster within a week.

The shot is designated to protect people against the Omicron strains that account for most new coronavirus infections.

Not only that, Pfizer says the new vaccine also protects people against older variants.

A Center for Disease Control (CDC) and Prevention Vaccine Advisory Committee is scheduled to meet next Thursday and Friday to discuss the booster.

In addition to Pfizer, Moderna submitted its Omicron booster to the FDA on Tuesday.

Currently, it is not known if the agency will authorize it before the CDC meets.

However, neither company's new shots have undergone clinical trials.

Article Topic Follows: CNN - National

Arlette Yousif joined KYMA in November 2020 as a Multi Media Journalist. She holds a BA in Journalism with a minor in Film.

You can reach out to Arlette for at arlette.yousif@kecytv.com.

If you have any story ideas, reach out to him at dillon.fuhrman@kecytv.com.

BE PART OF THE CONVERSATION

KYMA KECY is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.